A 109-amino-acid C-terminal fragment of Alzheimer's-disease amyloid precursor protein contains a sequence, -RHDS-, that promotes cell adhesion
- 15 December 1992
- journal article
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 288 (3) , 1053-1059
- https://doi.org/10.1042/bj2881053
Abstract
Amyloid beta (A beta), the major constituent of the fibrils composing senile plaques and vascular amyloid deposits in Alzheimer's disease (AD) and related disorders, is a 39-42-residue self-aggregating degradation peptide of a larger multidomain membrane glycoprotein designated amyloid precursor protein (APP). An array of biological functions has been assigned to different APP domains, including growth regulation, neurotoxicity, inhibitory activity of serine proteinases and promotion of cell-cell and cell-matrix interactions. A beta is generated through an as-yet-unknown catabolic pathway that by-passes or inhibits the cleavage of APP within the A beta sequence. We have identified a 16 kDa intermediate APP C-terminal fragment containing A beta in leptomeningeal vessels of aged normal individuals and AD patients by means of its immunoreactivity with a panel of four different anti-(APP C-terminal) antibodies, indicating a different pathway of APP processing. Previous studies have indicated that the APP C-terminal domain is the most likely to be involved in cell-matrix interactions. A 109-amino-acid construct C109 with a sequence analogous to the C-terminal of APP (positions 587-695 of APP695), similar in length and immunoreactivity to the 16 kDa fragment, was found to promote cell adhesion. By use of synthetic peptides, this activity was initially located to the extracellular 28 residues of A beta. Inhibition studies demonstrated that the sequence RHDS (amino acids 5-8 of A beta, corresponding to residues 601-604 of APP695 was responsible for the adhesion-promoting activity. The interaction is dependent on bivalent cations and can be blocked either by the tetrapeptides RHDS and RGDS or by an anti-(beta 1 integrin) antibody. Thus, through integrin-like surface receptors, APP or its derivative proteolytic fragments containing the sequence RHDS may modulate cell-cell or cell-matrix interactions.Keywords
This publication has 59 references indexed in Scilit:
- Peptides homologous to the amyloid protein of Alzheimer's disease containing a glutamine for glutamic acid substitution have accelerated amyloid fibril formationBiochemical and Biophysical Research Communications, 1991
- Exact cleavage site of Alzheimer amyloid precursor in neuronal PC-12 cellsNeuroscience Letters, 1991
- Abnormal and deficient processing of β-amyloid precursor protein in familial Alzheimer's disease lymphoblastoid cellsBiochemical and Biophysical Research Communications, 1991
- Intact Alzheimer amyloid precursor protein (APP) is present in platelet membranes and is encoded by platelet mRNABiochemical and Biophysical Research Communications, 1990
- Transforming growth factor-beta bound to soluble derivatives of the beta amyloid precursor protein of Alzheimer's diseaseBiochemical and Biophysical Research Communications, 1990
- Alzheimer's disease amyloid precursor protein is present in senile plaques and cerebrospinal fluid: Immunohistochemical and biochemical characterizationBiochemical and Biophysical Research Communications, 1989
- Amyloid beta protein precursor is a mitogenBiochemical and Biophysical Research Communications, 1989
- Ten to fourteen residue peptides of Alzheimer's disease protein are sufficient for amyloid fibril formation and its characteristic xray diffraction patternBiochemical and Biophysical Research Communications, 1987
- In vitro formation of amyloid fibrils from two synthetic peptides of different lengths homologous to alzheimer's disease β-proteinBiochemical and Biophysical Research Communications, 1986
- Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid proteinBiochemical and Biophysical Research Communications, 1984